Untitled Document
  Search
 

Home > Products > Medicines > Entrofuran-M
Entrofuran-M

DETAILS
COMPOSITION Each capsule contains Furazolidone IP 100 mg. & Metronidazole IP 300 mg. Each 5 ml. of suspension contains: Metronidazole benzoate IP equivalent to Metronidazole 100 mg., Furazolidone IP 33 mg. & Simethicone IP 25 mg.
INDICATIONS Mixed infections of dysentry, due to bacteria, amoeba like E. histolytica and Giardia lamblia and also food poisoning.
MODE OF ACTION

Metronidazole is effective against E. Hystolytica, Giardia, Anaerobes etc.. Furazolidone is a broad-spectrum anti- bacterial.

ADVERSE EFFECT Metronidazole- nausea, epigastric discomfort, metallic test, neuropathy, skin rash, urticaria, angioedema, leucopenia, seizures on prolonged therapy. Furazolidone - nausea, vomiting, diuiness, headache.
CONTRAINDICATION Metronidazole: neurological disorders, blood dyscrasias, first trimester of pregnancy. Furazolidone: Primaquine sensitivity, Infants below one month, alcohol.
SPECIAL PRECAUTIONS Pregnancy, lactation, geriatrics, urine colour turns orange.
DRUG INTERACTIONS Furazolidone: Alcohol, anorexiants, levodopa, TCAs, hypnotics and sedatives, hypoglycaemics. Metronidazole: Alcohol- Disulfirmam like reaction. Ampicillin, Doxycycline & Cotrimoxazole- synergism with this agent.
DOSAGE AND ADMINISTRATION: Adults: 1 capsule 3 to 4 times a day or as directed by physician. Children Upto 1 year- 2.5 ml., 1 to 5 years: 10 ml., above 5 years: 20 ml. All thrice daily or as directed by physician.

Powered by
Cyberax Tech : Web Hosting, Web Designing, Search Engine Optimization (SEO)